Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy

A. Boiardi, A. Silvani, A. Pozzi, M. Farinotti, L. Fariselli, G. Broggi, A. Salmaggi

Research output: Contribution to journalArticle

Abstract

We devised a treatment protocol for anaplastic gliomas consisting of: (a) chemotherapy prior to radiotherapy (b) a second chemotherapy regimen at tumor recurrence (c) repeated surgery whenever possible. 41 Anaplastic Astrocytoma (AA), 16 Anaplastic oligoastrocytoma (AOA) and 14 anaplastic oligodendroglioma (AOD) patients were treated. After surgery all patients received 5-6 cycles of carmustine + Cisplatinum chemotherapy. Radiotherapy was started during the last 2-3 cycles of chemotherapy. 17 patients (30.5%) were reoperated-on at recurrence. All recurring patients underwent PVC chemotherapy. At this moment disease recurred in 56 patients. Median TTP was 24.5, 38.7 and 58.2 months for AA, AOA and AOD respectively. Median ST was 38.8, 71.8 and 73 months. In conclusion our sandwich protocol of prior chemotherapy, overlapping irradiation with second chemotherapy and, in favourable cases, a second surgical intervention, is of benefit in patients with anaplastic gliomas.

Original languageEnglish
Pages (from-to)179-185
Number of pages7
JournalJournal of Neuro-Oncology
Volume34
Issue number2
DOIs
Publication statusPublished - 1997

Fingerprint

Glioma
Radiotherapy
Drug Therapy
Oligodendroglioma
Astrocytoma
Recurrence
Carmustine
Clinical Protocols
Polyvinyl Chloride
Neoplasms

Keywords

  • Anaplastic gliomas
  • Chemotherapy
  • Prognostic factors

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy. / Boiardi, A.; Silvani, A.; Pozzi, A.; Farinotti, M.; Fariselli, L.; Broggi, G.; Salmaggi, A.

In: Journal of Neuro-Oncology, Vol. 34, No. 2, 1997, p. 179-185.

Research output: Contribution to journalArticle

@article{f8858d118e3c467c972d7c7b2fc619a6,
title = "Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy",
abstract = "We devised a treatment protocol for anaplastic gliomas consisting of: (a) chemotherapy prior to radiotherapy (b) a second chemotherapy regimen at tumor recurrence (c) repeated surgery whenever possible. 41 Anaplastic Astrocytoma (AA), 16 Anaplastic oligoastrocytoma (AOA) and 14 anaplastic oligodendroglioma (AOD) patients were treated. After surgery all patients received 5-6 cycles of carmustine + Cisplatinum chemotherapy. Radiotherapy was started during the last 2-3 cycles of chemotherapy. 17 patients (30.5{\%}) were reoperated-on at recurrence. All recurring patients underwent PVC chemotherapy. At this moment disease recurred in 56 patients. Median TTP was 24.5, 38.7 and 58.2 months for AA, AOA and AOD respectively. Median ST was 38.8, 71.8 and 73 months. In conclusion our sandwich protocol of prior chemotherapy, overlapping irradiation with second chemotherapy and, in favourable cases, a second surgical intervention, is of benefit in patients with anaplastic gliomas.",
keywords = "Anaplastic gliomas, Chemotherapy, Prognostic factors",
author = "A. Boiardi and A. Silvani and A. Pozzi and M. Farinotti and L. Fariselli and G. Broggi and A. Salmaggi",
year = "1997",
doi = "10.1023/A:1005705624858",
language = "English",
volume = "34",
pages = "179--185",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "2",

}

TY - JOUR

T1 - Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy

AU - Boiardi, A.

AU - Silvani, A.

AU - Pozzi, A.

AU - Farinotti, M.

AU - Fariselli, L.

AU - Broggi, G.

AU - Salmaggi, A.

PY - 1997

Y1 - 1997

N2 - We devised a treatment protocol for anaplastic gliomas consisting of: (a) chemotherapy prior to radiotherapy (b) a second chemotherapy regimen at tumor recurrence (c) repeated surgery whenever possible. 41 Anaplastic Astrocytoma (AA), 16 Anaplastic oligoastrocytoma (AOA) and 14 anaplastic oligodendroglioma (AOD) patients were treated. After surgery all patients received 5-6 cycles of carmustine + Cisplatinum chemotherapy. Radiotherapy was started during the last 2-3 cycles of chemotherapy. 17 patients (30.5%) were reoperated-on at recurrence. All recurring patients underwent PVC chemotherapy. At this moment disease recurred in 56 patients. Median TTP was 24.5, 38.7 and 58.2 months for AA, AOA and AOD respectively. Median ST was 38.8, 71.8 and 73 months. In conclusion our sandwich protocol of prior chemotherapy, overlapping irradiation with second chemotherapy and, in favourable cases, a second surgical intervention, is of benefit in patients with anaplastic gliomas.

AB - We devised a treatment protocol for anaplastic gliomas consisting of: (a) chemotherapy prior to radiotherapy (b) a second chemotherapy regimen at tumor recurrence (c) repeated surgery whenever possible. 41 Anaplastic Astrocytoma (AA), 16 Anaplastic oligoastrocytoma (AOA) and 14 anaplastic oligodendroglioma (AOD) patients were treated. After surgery all patients received 5-6 cycles of carmustine + Cisplatinum chemotherapy. Radiotherapy was started during the last 2-3 cycles of chemotherapy. 17 patients (30.5%) were reoperated-on at recurrence. All recurring patients underwent PVC chemotherapy. At this moment disease recurred in 56 patients. Median TTP was 24.5, 38.7 and 58.2 months for AA, AOA and AOD respectively. Median ST was 38.8, 71.8 and 73 months. In conclusion our sandwich protocol of prior chemotherapy, overlapping irradiation with second chemotherapy and, in favourable cases, a second surgical intervention, is of benefit in patients with anaplastic gliomas.

KW - Anaplastic gliomas

KW - Chemotherapy

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=0031011048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031011048&partnerID=8YFLogxK

U2 - 10.1023/A:1005705624858

DO - 10.1023/A:1005705624858

M3 - Article

C2 - 9210066

AN - SCOPUS:0031011048

VL - 34

SP - 179

EP - 185

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -